Here you can find more information about the projects we are funding that are investigating therapeutic targets. Click on a project to find out more information and what the project means to a person living with MND.
These projects aim to understand the causes of MND and focus in on the pivotal biochemical processes involved in the disease that will provide a starting point for the development of new treatments.

Investigating the role of RNA binding proteins in FUS MND
Dr Nicol Birsa

Developing AAV-GRN gene therapy for MND
Dr Younbok Lee/Joe Reynolds

Investigating the role of miRNA in human stem cell models of MND
Dr Hamish Crerar

Role of axonal transport in cell models carrying MND mutations
Dr Andrew Tosolini

Determining the mechanisms behind astrocyte and microglia changes in MND
Dr Ben Clarke

Targeting ALS-dysregulated microRNAs in astrocytes
Prof Rob Layfield/Hannah Bailey

Glial engulfment of human synapses in MND
Dr Zsófia László

Investigating the mechanisms which lead to damage of synapses using models of MND
Prof Gareth Miles

Identifying the early biochemical signature of MND
Dr Alex Thompson

Synaptic dysfunction in FUS MND: A novel role for FUS in synaptic vesicle biology
Dr Caroline Vance

Using statistical models and machine learning to find MND subgroups
Dr Alfredo Iacoangeli

Molecular mechanisms of disease onset in TDP-43 related MND
Dr Frank Hirth/Tiziana Ercolani



Investigating synaptic dysfunction in MND
Dr Richard Mead/Dr Alannah Mole


Investigating whether gut-microbes contribute to MND
Prof Chris McDermott

Investigating changes in lipids in cell models of MND
Dr Agnes Nishimura

Confirming possible subgroups of MND
Dr Alfredo Iacoangeli/Dr Heather Marriott

Dissecting the genes involved in cognitive and behavioural symptoms in MND
Dr Ross Byrne

Investigating the effects of multiple gene mutations in the onset of MND
Prof Majid Hafezparast/Sarah Gornall


Investigating the role of C9orf72/SMCR8 in motor neuron communication in MND
Prof Kurt De Vos

Investigating why protein movement is disrupted in C9orf72 MND
Dr Daniel Solomon

Exploring striatal neuron dysfunction in C9orf72 MND-FTD cells
Dr Matthew Livesey/Manpreet Atwal
Exploring differences between male and female motor neurons in MND
Dr Jemeen Sreedharan

Genetic and environmental risk factors that combine with SARM1 in MND
Prof Michael Coleman/Adina Zhao

Role of transposable elements in MND development & progression
Prof John Quinn

Analysing axonal transport changes in MND
Prof Giampietro Schiavo/Alya Masoud Abdelhafid

Resolving the link between cell processes and axon length in a cell model of MND
Dr Andrea Serio

Understanding the role of NEAT1 in energy metabolism in MND
Dr Tatyana Shelkovnikova/Ruaridh Lang

Investigating mechanisms underlying the impaired hypoxia response in C9Orf72-related MND
Dr Ryan West/Ergita Balli

Investigating how C9orf72 MND may impact cell structure and shape
Dr Ryan West/Charlotte Gale


Dissecting FUS’ cytoplasmic toxic gain-of-function in MND
Dr Marc-David Ruepp/Juan Alcalde


Analysing gene changes in different brain cells in MND
Dr Johnathan Cooper-Knock

Modelling MND and Frontotemporal Dementia (FTD) in cell cultures
Dr Fiona LeBeau

Investigating the role of TBK1 in microglia behaviour in MND
Dr Owen Peters

Exploring faulty cell communication in human neurons and ways to restore it in MND/FTD
Prof Juan Burrone

Investigating the role of extracellular vesicles in MND and FTD
Dr Alex Thompson

Understanding the role of changes in the TBK1 gene in MND
Dr Sarah Langley/Sophie Shaw

Investigating faulty protein methylation in MND
Dr Judith Sleeman/ Emily Day

Identifying causes of neuron cell death in C9orf72 MND
Dr Teresa Niccoli

Investigating the role of TMEM106B in synapses in MND/FTD
Prof Kurt De Vos

Developing CCDC146 as a therapeutic target for MND
Dr Johnathan Cooper-Knock/Connie Treanor

RNA Binding Proteins in MND: From molecular mechanisms to target identification
Dr Matthew White